In terms of Regulation 31(1)(b) of SEBI (LODR) Regulations, 2015, OneSource Specialty Pharma has informed that it enclosed the shareholding pattern of the Company for the quarter ended December 31, 2024. The above information is also available on the website of the Company.
The above information is a part of company’s filings submitted to BSE.